Lacosamide tablet

DRUG4 trials

Sponsors

UCB BIOSCIENCES GmbH, UCB BIOSCIENCES, Inc., Kafrelsheikh University

Conditions

EpilepsyHealthyMigraine DisordersRenal Impairment

Phase 1

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects

CompletedNCT01796938

UCB BIOSCIENCES GmbHHealthy, Renal Impairment

Start: 2004-06-30End: 2004-11-30Updated: 2014-10-20

Phase 3

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

CompletedNCT02408523

UCB BIOSCIENCES, Inc.Epilepsy

Start: 2015-04-30End: 2019-06-30Updated: 2020-12-17

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

CompletedNCT02408549

UCB BIOSCIENCES, Inc.Epilepsy

Start: 2015-08-03End: 2023-03-30Updated: 2023-12-14

Lacosamide Versus Propranolol in Migraine

CompletedNCT05851781

Kafrelsheikh UniversityMigraine Disorders

Start: 2022-06-01End: 2023-08-30Updated: 2024-05-01

Related Papers

Long‐term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic–clonic seizures: An open‐label extension trial

Epilepsia2024-10-263 citations

Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial

Journal of Neurology Neurosurgery & Psychiatry2020-08-1877 citations